Close Menu

NEW YORK – Aytu BioScience said on Thursday it has reached a definitive deal with Biolidics to exclusively distribute that firm's coronavirus serology test in the US.

Under the terms of the deal, Englewood, California-based Aytu has committed to purchasing at least 1.25 million of Biolidics' COVID-19 IgG/IgM Rapid Tests within the first three months of the deal, including 500,000 tests in the first business day after the signing of the agreement.

Further details were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.